Together, these findings show that modulating Cx43 in non-cancerous MCF10A mammary epithelial cells does not alter proliferation, suggesting that ACT1-mediated modulation of gap junction activity toward reducing proliferation could be specific to breast cancer cells. This evidence concerns the gene GJA1 and breast carcinoma.